Search
forResearch 10 of 1000+
- The effect of St. John’s wort treatment on finasteride pharmacokinetics and identification of new phase I and phase II metabolites in humans
- Chapter 14 Principles of drug metabolism
- High-resolution mass spectrometric investigation of the phase I and II metabolites of finasteride in pig plasma, urine and bile
- Identification of Metabolites for the Novel 5α‐Reductase Inhibitor Epristeride In Vitro and Its Potential Impact on Doping Testing
- The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity.
- 138 Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles
- Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Identification of Finasteride Metabolites in Human Bile and Urine by High-Performance Liquid Chromatography/Tandem Mass Spectrometry
- Comparison of Activities Dependent on Glutathione S-Transferase and Cytochrome P-450 IA1 in Cultured Keratinocytes and Reconstructed Epidermal Models
Learn 1 of 27
All learn results →Community 10 of 420
- Phase II topical dut study - outperforms oral fin with a minor DHT reduction
- GT20029 phase II results release date?
- About Pyrilutamide Phase II US Trial
- KX-826 1% Phase II Results from China Just Dropped
- KX-826 Phase II Results Just Dropped (Male AGA) – Key Takeaways
- GT20029 - Promising phase II results
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
- Where are GT20029 phase II results?
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- So why did the first pyrilutamide phase III fail?